The cyclin-dependent kinase Cdk2 regulates thymocyte apoptosis

被引:96
|
作者
Hakem, A
Sasaki, T
Kozieradzki, I
Penninger, JM
机构
[1] Univ Toronto, Ontario Canc Inst, Amgen Inst, Toronto, ON M5G 2C1, Canada
[2] Univ Toronto, Dept Immunol, Toronto, ON M5G 2C1, Canada
[3] Univ Toronto, Dept Med Biophys, Toronto, ON M5G 2C1, Canada
来源
JOURNAL OF EXPERIMENTAL MEDICINE | 1999年 / 189卷 / 06期
关键词
cyclin-dependent kinase 2; apoptosis; cell cycle; thymocyte;
D O I
10.1084/jem.189.6.957
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Aberrant activation of cell cycle molecules has been postulated to play a role in apoptosis ("catastrophic cell. cycle"). Here we show that in noncycling developing thymocytes, the cyclin-dependent kinase Cdk2 is activated in response to all specific and nonspecific apoptotic stimuli tested, including peptide-specific thymocyte apoptosis. Cdk2 was found to function upstream of the tumor suppressor p53, transactivation of the death promoter Bar, alterations of mitochondrial permeability, Bcl-2, caspase activation, and caspase-dependent proteolytic cleavage of the retinoblastoma protein. Inhibition of Cdk2 completely protected thymocytes from apoptosis, mitochondrial changes, and caspase activation. These data provide the first evidence that Cdk2 activity is crucial for the induction of thymocyte apoptosis.
引用
收藏
页码:957 / 967
页数:11
相关论文
共 50 条
  • [41] Targets of the cyclin-dependent kinase Cdk1
    Ubersax, JA
    Woodbury, EL
    Quang, PN
    Paraz, M
    Blethrow, JD
    Shah, K
    Shokat, KM
    Morgan, DO
    NATURE, 2003, 425 (6960) : 859 - 864
  • [42] A Requirement for Cyclin-Dependent Kinase 6 in Thymocyte Development and Tumorigenesis
    Hu, Miaofen G.
    Deshpande, Amit
    Enos, Miriam
    Mao, Daqin
    Hinds, Elisabeth A.
    Hu, Guo-fu
    Chang, Rui
    Guo, Zhuyan
    Dose, Marei
    Mao, Changchuin
    Tsichlis, Philip N.
    Gounari, Fotini
    Hinds, Philip W.
    CANCER RESEARCH, 2009, 69 (03) : 810 - 818
  • [43] Cyclin-dependent kinase 2 regulates the interaction of Axin with β-catenin
    Kim, SI
    Park, CS
    Lee, MS
    Kwon, MS
    Jho, E
    Song, WK
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2004, 317 (02) : 478 - 483
  • [44] Expression of the cyclin-dependent kinase 2 gene (cdk2) influences ovarian development in the ridgetail white prawn, Exopalaemon carinicauda
    Zhang, Pan
    Hua, Songsong
    Li, Yongchuang
    Zhang, Simian
    Liu, Xue
    Shi, Tingting
    Wang, Panpan
    Yan, Binlun
    Li, Jitao
    Gao, Huan
    AQUACULTURE REPORTS, 2022, 25
  • [45] Cyclin-dependent kinase 2 protects podocytes from apoptosis
    Pauliina Saurus
    Sara Kuusela
    Vincent Dumont
    Eero Lehtonen
    Christopher L. Fogarty
    Mariann I. Lassenius
    Carol Forsblom
    Markku Lehto
    Moin A. Saleem
    Per-Henrik Groop
    Sanna Lehtonen
    Scientific Reports, 6
  • [46] Cyclin-dependent kinase 2 protects podocytes from apoptosis
    Saurus, Pauliina
    Kuusela, Sara
    Dumont, Vincent
    Lehtonen, Eero
    Fogarty, Christopher L.
    Lassenius, Mariann I.
    Forsblom, Carol
    Lehto, Markku
    Saleem, Moin A.
    Groop, Per-Henrik
    Lehtonen, Sanna
    SCIENTIFIC REPORTS, 2016, 6
  • [47] Concise, flexible syntheses of 4-(4-imidazolyl)pyrimidine cyclin-dependent kinase 2 (CDK2) inhibitors
    Toumi, Mathieu
    Barbazanges, Marion
    Kroll, Sebastian H. B.
    Patel, Hetal
    Ali, Simak
    Coombes, R. Charles
    Barrett, Anthony G. M.
    TETRAHEDRON LETTERS, 2010, 51 (47) : 6126 - 6128
  • [48] Understanding and modulating cyclin-dependent kinase inhibitor specificity: molecular modeling and biochemical evaluation of pyrazolopyrimidinones as CDK2/cyclin A and CDK4/cyclin D1 inhibitors
    Rossi, KA
    Markwalder, JA
    Seitz, SP
    Chang, CH
    Cox, S
    Boisclair, MD
    Brizuela, L
    Brenner, SL
    Stouten, PFW
    JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN, 2005, 19 (02) : 111 - 122
  • [49] Understanding and modulating cyclin-dependent kinase inhibitor specificity: molecular modeling and biochemical evaluation of pyrazolopyrimidinones as CDK2/cyclin A and CDK4/cyclin D1 inhibitors
    Karen A. Rossi
    Jay A. Markwalder
    Steven P. Seitz
    Chong-Hwan Chang
    Sarah Cox
    Michael D. Boisclair
    Leonardo Brizuela
    Stephen L. Brenner
    Pieter F. W. Stouten
    Journal of Computer-Aided Molecular Design, 2005, 19 : 111 - 122
  • [50] Cyclin Dependent Kinase 2 (CDK2) Inhibitors in Oncology Clinical Trials: A Review
    House, Isabelle
    Valore-Caplan, Mari
    Maris, Elijah
    Falchook, Gerald S.
    JOURNAL OF IMMUNOTHERAPY AND PRECISION ONCOLOGY, 2025, 8 (01) : 47 - 54